BRD7 Antikörper
Kurzübersicht für BRD7 Antikörper (ABIN7252303)
Target
Alle BRD7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    - 
                                            Produktmerkmale
- Polyclonal Antibody
- 
                                            Aufreinigung
- Antigen affinity purification
- 
                                            Immunogen
- Fusion protein of human BRD7
- 
                                            Isotyp
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- IHC 1:40-1:200, ELISA 1:5000-1:10000
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Konzentration
- 0.6 mg/mL
- 
                                            Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
- 
                                            Konservierungsmittel
- Sodium azide
- 
                                            Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Lagerung
- -20 °C
- 
                                            Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
 
- 
                                            
- 
    - BRD7 (Bromodomain Containing 7 (BRD7))
- 
                                            Andere Bezeichnung
- BRD7
- 
                                            Hintergrund
- This gene encodes a protein which is a member of the bromodomain-containing protein family. The product of this gene has been identified as a component of one form of the SWI/SNF chromatin remodeling complex, and as a protein which interacts with p53 and is required for p53-dependent oncogene-induced senescence which prevents tumor growth. Pseudogenes have been described on chromosomes 2, 3, 6, 13 and 14. Alternative splicing results in multiple transcript variants.
- 
                                            UniProt
- Q9NPI1
 Target
- 
                    
 
                                     
                                     
                                    